- £10.16m
- £8.56m
- £2.86m
RCS - Angle PLC - HER2 presentation at SABCS
AnnouncementRCS - Angle PLC - Parsortix based PD-L1 assay showcased at AACR
AnnouncementRCS - Angle PLC - Research on HER2 assay kit showcased at AACR
AnnouncementRCS - Angle PLC - ANGLE presents two posters at EACR
AnnouncementRCS - Angle PLC - Parsortix enriched CTC & ctDNA in NSCLC patients
AnnouncementRCS - Angle PLC - Publication demonstrates CTC profiling potential
AnnouncementRCS - Angle PLC - 100th publication supporting Parsortix system use
AnnouncementREG - Angle PLC - Half-year Report
AnnouncementREG - Angle PLC - Exclusive agreement for DNA NGS panel
AnnouncementRCS - Angle PLC - Agreement with Recursion Pharmaceuticals
AnnouncementREG - Angle PLC - Notice of Interim Results and Webcast
AnnouncementRCS - Angle PLC - Data supporting FDA approval published in Journal
AnnouncementRCS - Angle PLC - Independent Parsortix study
AnnouncementREG - Angle PLC - Standard form for notification of major holdings
AnnouncementREG - Angle PLC - Standard form for notification of major holdings
AnnouncementREG - Angle PLC - Result of 2024 Annual General Meeting
AnnouncementREG - AIM - AIM Notice - 24/06/2024
AnnouncementREG - Angle PLC - Result of open offer
AnnouncementREG - Angle PLC - Posting of 2023 Annual Report & Notice of the AGM
Announcement